Home
About
Overview
Sharing Data
ORCID
Help
History (79)
Balancing the risks and benefits of biologic therapy in inflammatory bowel diseases.
EGFR pharmacogenomics: the story continues to mutate and evolve.
Pembrolizumab and lenvatinib versus carboplatin and paclitaxel as first-line therapy for advanced or recurrent endometrial cancer: A Markov analysis.
The RISE FOR HEALTH study: Methods for in-person musculoskeletal assessment.
Robotic Living Donor Hysterectomy for Uterus Transplantation: An Update on Donor and Recipient Outcomes.
See All 79 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Robotic Living Donor Hysterectomy for Uterus Transplantation: An Update on Donor and Recipient Outcomes.
Robotic Living Donor Hysterectomy for Uterus Transplantation: An Update on Donor and Recipient Outcomes. J Clin Med. 2024 Jul 17; 13(14).
View in:
PubMed
authors with profiles
Giuliano Testa